254 related articles for article (PubMed ID: 15142230)
21. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.
Ng A; Chander RJ; Tan LC; Kandiah N
Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
[TBL] [Abstract][Full Text] [Related]
23. [The effect of amantadine sulfate on cognitive disorders in patients with Parkinson's disease].
Iablonskaia AIu; Fedorova NV; Bel'gusheva ME
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):24-30. PubMed ID: 20639853
[TBL] [Abstract][Full Text] [Related]
24. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.
Estanga A; Rodriguez-Oroz MC; Ruiz-Martinez J; Barandiaran M; Gorostidi A; Bergareche A; Mondragon E; Lopez de Munain A; Marti-Masso JF
Parkinsonism Relat Disord; 2014 Oct; 20(10):1097-100. PubMed ID: 25127457
[TBL] [Abstract][Full Text] [Related]
25. How well do caregivers detect mild cognitive change in Parkinson's disease?
Naismith SL; Pereira M; Shine JM; Lewis SJ
Mov Disord; 2011 Jan; 26(1):161-4. PubMed ID: 20818607
[TBL] [Abstract][Full Text] [Related]
26. Depression and cognitive impairment in patients with mild parkinsonian signs.
Uemura Y; Wada-Isoe K; Nakashita S; Nakashima K
Acta Neurol Scand; 2013 Sep; 128(3):153-9. PubMed ID: 23397887
[TBL] [Abstract][Full Text] [Related]
27. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
Hanna-Pladdy B; Pahwa R; Lyons KE
J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
[TBL] [Abstract][Full Text] [Related]
28. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
Grosset KA; Grosset DG
Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
[TBL] [Abstract][Full Text] [Related]
29. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
30. The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease.
Sławek J; Wieczorek D; Derejko M; Dubaniewicz M; Brockhuis B; Sitek E; Wilczewska L; Roszmann A; Lass P
Neurol Neurochir Pol; 2008; 42(6):505-12. PubMed ID: 19235103
[TBL] [Abstract][Full Text] [Related]
31. [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease].
Li W; Zhao JH; Sun SG; Zhang JW; Suo AQ; Ma MM
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):301-3. PubMed ID: 21419002
[TBL] [Abstract][Full Text] [Related]
32. Cognitive function assessment in idiopathic Parkinson's disease.
Piovezan MR; Teive HA; Piovesan EJ; Mader MJ; Werneck LC
Arq Neuropsiquiatr; 2007 Dec; 65(4A):942-6. PubMed ID: 18094850
[TBL] [Abstract][Full Text] [Related]
33. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
[TBL] [Abstract][Full Text] [Related]
34. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychological profile of patients with Parkinson's disease without dementia.
Janvin C; Aarsland D; Larsen JP; Hugdahl K
Dement Geriatr Cogn Disord; 2003; 15(3):126-31. PubMed ID: 12584427
[TBL] [Abstract][Full Text] [Related]
36. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
37. Gait patterns in Parkinsonian patients with or without mild cognitive impairment.
Amboni M; Barone P; Iuppariello L; Lista I; Tranfaglia R; Fasano A; Picillo M; Vitale C; Santangelo G; Agosti V; Iavarone A; Sorrentino G
Mov Disord; 2012 Oct; 27(12):1536-43. PubMed ID: 23032876
[TBL] [Abstract][Full Text] [Related]
38. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
Parrao T; Chana P; Venegas P; Behrens MI; Aylwin ML
Neurodegener Dis; 2012; 10(1-4):179-82. PubMed ID: 22343138
[TBL] [Abstract][Full Text] [Related]
39. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
40. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
